Abstract
Adjuvant immunochemotherapy using schizophyllan (SPG), an extract from the culture broth ofSchizophyllum commune Fries, was prescribed at random for 326 Japanese patients with resectable gastric cancer. The overall survival rates for 3 years did not differ between the SPG and control groups. In 62 patients with stage I gastric cancer and 67 with stage II, there was little difference in the 3-year survival rates. The survival rates for 100 patients with stage III were enhanced at p=0.0811 in the SPG group, as compared to the controls. The survival rates in 97 patients with stage IV cancer were much the same. These results warrant further application of this immunopotentiating drug for treating patients with resectable gastric cancer.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Fujimoto S, Akao T, Itoh B, Kitsukawa Y, Takahashi M, Minami T, Ishigami H, Miyazaki M, Amamiya K, Ohyama Y, Kure M. Protracted oral chemotherapy with fluorinated pyrimidines as an adjuvant to surgical treatment for stomach cancer. Ann Surg 1977; 185: 462–466.
Kondo T, Inokuchi K, Hattori T, Inoue K, Taguchi T, Akiyama H, Abe O, Ito I, Nakajima T, Muto T, Kikuchi K, Kasai Y, Sugie S, Hayasaka A. Multi-hospital randomized study on the adjuvant chemotherapy with mitomycin-C and futraful for gastric cancer. V. Estimation of five-year survival rate. Jpn J Cancer Chemother 1982; 9: 2016–2024. (in Japanese)
Carter KS, Comis RL. Gastric cancer: Current status of treatment. J Natl Cancer Inst 1977; 58: 567–578.
Yamamoto T, Yamashita T, Tsubura E. Inhibition of pulmonary metastasis of Lewis lung carcinoma by a glucan, Schizophyllan. Invasion and Metastasis 1981; 1: 71–84.
Komatsu N, Okubo S, Kikumoto K, Kimura K, Saito G, Sakai S. Host-mediated antitumor action of schizophyllan, a glucan produced by Schizophyllum Commune. Gann 1969; 60: 137–144.
Mizuhira V, Shiihashi M, Shibuya K, Amamiya K, Hase T. The fate of3H-SPG administered to sarcoma-180 grafted mice. Electron Microscopy 1980; 2: 382–383.
Hattori T, Ito I, Hirata K. Large dose administration of mitomycin C during gastrectomy followed by homologous bone marrow transplantation. Gann 1964; 55: 211–224.
Japanese Research Society for Gastric Cancer. The General Rules for the Gastric Cancer Study in Surgery and Pathology. Jpn J Surg 1981; 11: 127–139.
Orita K, Mannami T, Miwa H, Ohta T, Nakahara H, Konaga E, Tanaka S. Immunotherapy for advanced gastric cancer and colorectal cancer using BCG cell-wall skelton. Gann Monograph, Cancer Res 1978; 21: 163–171.
Hattori T, Niimoto M, Koh T, Nakano A, Oride M, Takiyama W, Nishimawari K. Postoperative long-term immunochemotherapy with mitomycin-C, PSK and FT-207 in gastric cancer. Jpn J Surg 1979; 9: 110–117.
Fujimoto S, Takahashi M, Minami T, Ishigami H, Miyazaki M, Itoh K. Clinical value of immunochemotherapy with OK-432 or PSK for stomach cancer patients. Jpn J Surg 1979; 9: 190–196.
Akao T, Fujimoto S, Itoh B, Kitsukawa Y, Takahashi M, Minami T, Ishigami H, Miyazaki M, Itoh K. Fundamental and clinical studies on antitumor polysaccharide. Jpn J Cancer Chemother 1980; 7: 321–326. (in Japanese)
Minami T. Immunological studies on patients with gastrointestinal cancer—with particular emphasis on influence of surgery and immunomodulators—. J Jpn Soc Cancer Ther 1981; 16: 1248–1256. (in Japanese)
Author information
Authors and Affiliations
Consortia
Rights and permissions
About this article
Cite this article
Fujimoto, S., Furue, H., Kimura, T. et al. Clinical evaluation of schizophyllan adjuvant immunochemotherapy for patients with resectable gastric cancer —A randomized controlled trial—. The Japanese Journal of Surgery 14, 286–292 (1984). https://doi.org/10.1007/BF02469643
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02469643